Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2015

01-12-2015 | Research Article

Problems with oral formulations prescribed to children: a focus group study of healthcare professionals

Authors: Rebecca Venables, Heather Stirling, Hannah Batchelor, John Marriott

Published in: International Journal of Clinical Pharmacy | Issue 6/2015

Login to get access

Abstract

Background There is evidence to suggest that adherence with prescribed medication is lower amongst adolescents and children than in adults. Medication adherence rates between 11 and 93 % in paediatric patients have been reported. More research needs to be carried out in order to understand why medicines adherence is low and how adherence can be improved in children with long-term conditions. Personal communication with paediatricians in secondary care has highlighted that problems are most likely to be encountered by parents, carers, nurses and children themselves when administering medicines for prevalent long-term childhood conditions. Objective To explore problems with oral medicines prescribed to paediatric patients from the perspectives of medical practitioners, pharmacists and nurses. Setting Two NHS trusts in the West Midlands, UK. Methods Four focus groups (FG) were conducted. Five nurses, eight medical practitioners and six pharmacists participated in focus groups. The themes explored were problems experienced when prescribing, dispensing and administering oral medicines for children. Main outcome measure Themes evolving from Healthcare professionals reports on problems with administering medicines to paediatric patients. Results Two main themes: sensory and non-sensory emerged from the data. Included within these were taste, texture, colour, smell, size, swallowing, quantity, volume and manipulation with food. Taste was the most commonly reported barrier to medicines administration. Texture was reported to be a significant problem for the learning disability population. Medicines manipulation techniques were revealed across the groups, yet there was limited knowledge regarding the evidence base for such activity. Problems surrounding the supply of Specials medicines were discussed in-depth by the pharmacists. Conclusion Organoleptic and physical properties of medicines are key barriers to medicines administration. A robust scientific evidence-based approach is warranted to inform standardised protocols guiding healthcare professionals to support safe and effective medicines manipulation across all settings. Pharmacists’ knowledge of Specials medicines needs to be recognised as a valuable resource for doctors. Findings of this study should help to optimise paediatric prescribing and direct future formulation work.
Literature
1.
go back to reference Staples B, Bravender T. Drug compliance in adolescents: assessing and managing modifiable risk factors. Pediatr Drugs. 2002;4(8):503–13.CrossRef Staples B, Bravender T. Drug compliance in adolescents: assessing and managing modifiable risk factors. Pediatr Drugs. 2002;4(8):503–13.CrossRef
2.
go back to reference Winnick S, Lucas DO, Hartman AL, Toll D. How do you improve compliance? Pediatrics. 2005;115(6):e718–24.CrossRefPubMed Winnick S, Lucas DO, Hartman AL, Toll D. How do you improve compliance? Pediatrics. 2005;115(6):e718–24.CrossRefPubMed
3.
go back to reference Burkhart P, Dunbar-Jacob J. Adherence research in the pediatric and adolescent populations: a decade in review. In: Hayman L, Mahon M, Turner J, editors. Chronic illness in children: an evidence-based approach. 1st ed. New York: Springer; 2002. p. 199–229. Burkhart P, Dunbar-Jacob J. Adherence research in the pediatric and adolescent populations: a decade in review. In: Hayman L, Mahon M, Turner J, editors. Chronic illness in children: an evidence-based approach. 1st ed. New York: Springer; 2002. p. 199–229.
4.
go back to reference Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL. Developing paediatric medicines: identifying the needs and recognizing the challenges. J Pharm Pharmacol. 2007;59(8):1043–55.CrossRefPubMed Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL. Developing paediatric medicines: identifying the needs and recognizing the challenges. J Pharm Pharmacol. 2007;59(8):1043–55.CrossRefPubMed
5.
go back to reference Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000;320(7227):79–82.PubMedCentralCrossRefPubMed Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000;320(7227):79–82.PubMedCentralCrossRefPubMed
7.
go back to reference Skwierczynski C, Conroy S. How long does it take to administer oral medicines to children? Paediatr Perinat Drug Ther. 2008;8(4):145–9.CrossRef Skwierczynski C, Conroy S. How long does it take to administer oral medicines to children? Paediatr Perinat Drug Ther. 2008;8(4):145–9.CrossRef
8.
go back to reference Richey R, Donnell C, Shah U, Barker CE, Craig JV, Ford JL, et al. An investigation of drug manipulation for dose accuracy in paediatric practice: the modric study. Arch Dis Child. 2011;96(4):e1.CrossRef Richey R, Donnell C, Shah U, Barker CE, Craig JV, Ford JL, et al. An investigation of drug manipulation for dose accuracy in paediatric practice: the modric study. Arch Dis Child. 2011;96(4):e1.CrossRef
11.
go back to reference Brackis-Cott E, Mellins CA, Abrams E, Reval T, Dolezal C. Pediatric HIV medication adherence: the views of medical providers from two primary care programs. J Pediatr Health Care. 2003;17(5):252–60.CrossRefPubMed Brackis-Cott E, Mellins CA, Abrams E, Reval T, Dolezal C. Pediatric HIV medication adherence: the views of medical providers from two primary care programs. J Pediatr Health Care. 2003;17(5):252–60.CrossRefPubMed
12.
go back to reference Akram G, Mullen AB. Paediatric nurses’ knowledge and practice of mixing medication into foodstuff. IJPP. 2012;20(3):191–8. Akram G, Mullen AB. Paediatric nurses’ knowledge and practice of mixing medication into foodstuff. IJPP. 2012;20(3):191–8.
13.
go back to reference Mukattash T, Hawwa AF, Trew K, McElnay JC. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol. 2011;67(5):449–61.CrossRefPubMed Mukattash T, Hawwa AF, Trew K, McElnay JC. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol. 2011;67(5):449–61.CrossRefPubMed
14.
go back to reference Mukattash TL, Wazaify M, Khuri-Boulos N, Jarab A, Hawwa AF, McElnay JC. Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing. IJCP. 2011;33(6):964–73.PubMed Mukattash TL, Wazaify M, Khuri-Boulos N, Jarab A, Hawwa AF, McElnay JC. Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing. IJCP. 2011;33(6):964–73.PubMed
16.
go back to reference Krueger RA, Casey MA. Focus groups: a practical guide for applied research. 3rd ed. London: Sage; 2000. Krueger RA, Casey MA. Focus groups: a practical guide for applied research. 3rd ed. London: Sage; 2000.
17.
go back to reference Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.PubMedCentralCrossRefPubMed Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.PubMedCentralCrossRefPubMed
18.
go back to reference Paediatric Formulary Committee. BNF for children (BNFC). London: Pharmaceutical Press; 2011–2012. Paediatric Formulary Committee. BNF for children (BNFC). London: Pharmaceutical Press; 2011–2012.
20.
go back to reference Baguley D, Lim E, Bevan A, Pallet A, Faust SN. Prescribing for children—taste and palatability affect adherence to antibiotics: a review. Arch Dis Child. 2012;97(3):293–7.CrossRefPubMed Baguley D, Lim E, Bevan A, Pallet A, Faust SN. Prescribing for children—taste and palatability affect adherence to antibiotics: a review. Arch Dis Child. 2012;97(3):293–7.CrossRefPubMed
21.
go back to reference Chung T, Hoffer FA, Connor L, Zurakowski D, Burrows PE. The use of oral pentobarbital sodium (Nembutal) versus oral chloral hydrate in infants undergoing CT and MR imaging—a pilot study. Pediatr Radiol. 2000;30(5):332–5.CrossRefPubMed Chung T, Hoffer FA, Connor L, Zurakowski D, Burrows PE. The use of oral pentobarbital sodium (Nembutal) versus oral chloral hydrate in infants undergoing CT and MR imaging—a pilot study. Pediatr Radiol. 2000;30(5):332–5.CrossRefPubMed
22.
go back to reference Lucas-Bouwman ME, Roorda RJ, Jansman FGA, Brand PLP. Crushed prednisolone tablets or oral solution for acute asthma? Arch Dis Child. 2001;84(4):347–8.PubMedCentralCrossRefPubMed Lucas-Bouwman ME, Roorda RJ, Jansman FGA, Brand PLP. Crushed prednisolone tablets or oral solution for acute asthma? Arch Dis Child. 2001;84(4):347–8.PubMedCentralCrossRefPubMed
23.
go back to reference Field D, Garland M, Williams K. Correlates of specific childhood feeding problems. J Paediatr Child Health. 2003;39(4):299–304.CrossRefPubMed Field D, Garland M, Williams K. Correlates of specific childhood feeding problems. J Paediatr Child Health. 2003;39(4):299–304.CrossRefPubMed
24.
go back to reference Czyzewski D, Calles N, Runyan R, Lopez M. Teaching and maintaining pill swallowing in HIV-infected children. AIDS Reader-New York. 2000;10(2):88–95. Czyzewski D, Calles N, Runyan R, Lopez M. Teaching and maintaining pill swallowing in HIV-infected children. AIDS Reader-New York. 2000;10(2):88–95.
25.
go back to reference Garvie PA, Lensing S, Rai SN. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Pediatrics. 2007;119(4):e893–9.CrossRefPubMed Garvie PA, Lensing S, Rai SN. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Pediatrics. 2007;119(4):e893–9.CrossRefPubMed
26.
go back to reference Gibb DM, Goodall RL, Giacomet V, Mcgee L, Compagnucci A, Lyall H, et al. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J. 2003;22(1):56–62.CrossRefPubMed Gibb DM, Goodall RL, Giacomet V, Mcgee L, Compagnucci A, Lyall H, et al. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J. 2003;22(1):56–62.CrossRefPubMed
27.
go back to reference Marhefka S, Farley J, Rodrigue J, Sandrik L, Sleasman J, Tepper V. Clinical assessment of medication adherence among HIV-infected children: examination of the treatment interview protocol (TIP). AIDS Care. 2004;16(3):323–37.CrossRefPubMed Marhefka S, Farley J, Rodrigue J, Sandrik L, Sleasman J, Tepper V. Clinical assessment of medication adherence among HIV-infected children: examination of the treatment interview protocol (TIP). AIDS Care. 2004;16(3):323–37.CrossRefPubMed
28.
go back to reference Paranthaman K, Kumarasamy N, Bella D, Webster P. Factors influencing adherence to anti-retroviral treatment in children with human immunodeficiency virus in South India—a qualitative study. AIDS Care. 2009;21(8):1025–31.CrossRefPubMed Paranthaman K, Kumarasamy N, Bella D, Webster P. Factors influencing adherence to anti-retroviral treatment in children with human immunodeficiency virus in South India—a qualitative study. AIDS Care. 2009;21(8):1025–31.CrossRefPubMed
29.
go back to reference Reddington C, Cohen J, Baldillo A, Toye M, Smith D, Kneut C, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19(12):1148–53.CrossRefPubMed Reddington C, Cohen J, Baldillo A, Toye M, Smith D, Kneut C, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19(12):1148–53.CrossRefPubMed
30.
go back to reference Roberts KJ. Barriers to antiretroviral medication adherence in young HIV-infected children. Youth Soc. 2005;37(2):230–45.CrossRef Roberts KJ. Barriers to antiretroviral medication adherence in young HIV-infected children. Youth Soc. 2005;37(2):230–45.CrossRef
31.
go back to reference Ekins-Daukes S, Helms PJ, Taylor MW, McLay JS. Off-label prescribing to children: attitudes and experience of general practitioners. Br J Clin Pharmacol. 2005;60(2):145–9.PubMedCentralCrossRefPubMed Ekins-Daukes S, Helms PJ, Taylor MW, McLay JS. Off-label prescribing to children: attitudes and experience of general practitioners. Br J Clin Pharmacol. 2005;60(2):145–9.PubMedCentralCrossRefPubMed
33.
go back to reference Bowles A, Keane J, Ernest T, Clapham D, Tuleu C. Specific aspects of gastro-intestinal transit in children for drug delivery design. Int J Pharm. 2010;395(1):37–43.CrossRefPubMed Bowles A, Keane J, Ernest T, Clapham D, Tuleu C. Specific aspects of gastro-intestinal transit in children for drug delivery design. Int J Pharm. 2010;395(1):37–43.CrossRefPubMed
34.
go back to reference Nguyen TMU, Lau ET, Steadman KJ, Cichero JA, Dingle K, Nissen L. Pharmacist, general practitioner, and nurse perceptions, experiences, and knowledge of medication dosage form modification. Integr Pharm Res Pract. 2014;3:1–9.CrossRef Nguyen TMU, Lau ET, Steadman KJ, Cichero JA, Dingle K, Nissen L. Pharmacist, general practitioner, and nurse perceptions, experiences, and knowledge of medication dosage form modification. Integr Pharm Res Pract. 2014;3:1–9.CrossRef
35.
go back to reference Nissen LM, Haywood A, Steadman KJ. Solid medication dosage form modification at the bedside and in the pharmacy of Queensland hospitals. J Pharm Pract Res. 2009;39(2):129–34.CrossRef Nissen LM, Haywood A, Steadman KJ. Solid medication dosage form modification at the bedside and in the pharmacy of Queensland hospitals. J Pharm Pract Res. 2009;39(2):129–34.CrossRef
36.
go back to reference Burridge N, Deidun D. Australian don’t rush to crush handbook. Therapeutic options for people unable to swallow solid oral medicines. 1st ed. Collingwood: The Society of Hospital Pharmacists of Australia; 2011. Burridge N, Deidun D. Australian don’t rush to crush handbook. Therapeutic options for people unable to swallow solid oral medicines. 1st ed. Collingwood: The Society of Hospital Pharmacists of Australia; 2011.
38.
go back to reference Manrique-Torres YJ, Lee DJ, Islam F, Nissen LM, Cichero JA, Stokes JR, Steadman KJ. Crushed tablets: does the administration of food vehicles and thickened fluids to aid medication swallowing alter drug release? J Pharm Pharm Sci. 2014;17(2):207–19. Manrique-Torres YJ, Lee DJ, Islam F, Nissen LM, Cichero JA, Stokes JR, Steadman KJ. Crushed tablets: does the administration of food vehicles and thickened fluids to aid medication swallowing alter drug release? J Pharm Pharm Sci. 2014;17(2):207–19.
39.
go back to reference Venables R, Stirling H, Marriott J. Poster 0073 Healthcare professionals’ understanding of children’s medicines. IJPP. 2012;20(Supplement 2):68–9. Venables R, Stirling H, Marriott J. Poster 0073 Healthcare professionals’ understanding of children’s medicines. IJPP. 2012;20(Supplement 2):68–9.
40.
go back to reference Spomer N, Klingmann V, Stoltenberg I, Lerch C, Meissner T, Breitkreutz J. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study. Arch Dis Child. 2012;97(3):283–6.CrossRefPubMed Spomer N, Klingmann V, Stoltenberg I, Lerch C, Meissner T, Breitkreutz J. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study. Arch Dis Child. 2012;97(3):283–6.CrossRefPubMed
41.
go back to reference Thomson SA, Tuleu C, Wong IC, Keady S, Pitt KG, Sutcliffe AG. Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics. 2009;123(2):e235–8.CrossRefPubMed Thomson SA, Tuleu C, Wong IC, Keady S, Pitt KG, Sutcliffe AG. Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics. 2009;123(2):e235–8.CrossRefPubMed
42.
go back to reference Gau SS, Shen H, Chou M, Tang C, Chiu Y, Gau C. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol. 2006;16(3):286–97.CrossRefPubMed Gau SS, Shen H, Chou M, Tang C, Chiu Y, Gau C. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol. 2006;16(3):286–97.CrossRefPubMed
43.
go back to reference Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(11):1006–12.CrossRefPubMed Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(11):1006–12.CrossRefPubMed
44.
go back to reference Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(11):1035–41.CrossRefPubMed Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(11):1035–41.CrossRefPubMed
45.
go back to reference Shah CA. Adherence to high activity antiretroviral therapy (HAART) in pediatric patients infected with HIV: issues and interventions. Indian J Pediatr. 2007;74(1):55–60.CrossRefPubMed Shah CA. Adherence to high activity antiretroviral therapy (HAART) in pediatric patients infected with HIV: issues and interventions. Indian J Pediatr. 2007;74(1):55–60.CrossRefPubMed
47.
go back to reference GRIP Webinar (online conference) GRIP Work Package 5 “Meet the Expert” on paediatric formulations 2013. GRIP Webinar (online conference) GRIP Work Package 5 “Meet the Expert” on paediatric formulations 2013.
48.
go back to reference Glass BD, Haywood A. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products. J Pharm Pharmaceut Sci (www. cspsCanada.org). 2015;9(3):398–426. Glass BD, Haywood A. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products. J Pharm Pharmaceut Sci (www. cspsCanada.org). 2015;9(3):398–426.
49.
go back to reference Haywood A, Glass BD. Liquid dosage forms extemporaneously prepared from commercially available products–considering new evidence on stability. J Pharm Pharm Sci. 2013;16(3):441–55.PubMed Haywood A, Glass BD. Liquid dosage forms extemporaneously prepared from commercially available products–considering new evidence on stability. J Pharm Pharm Sci. 2013;16(3):441–55.PubMed
50.
go back to reference McKenzie M. Administration of oral medications to infants and young children. US Pharmacist. 1981;6:55–67. McKenzie M. Administration of oral medications to infants and young children. US Pharmacist. 1981;6:55–67.
Metadata
Title
Problems with oral formulations prescribed to children: a focus group study of healthcare professionals
Authors
Rebecca Venables
Heather Stirling
Hannah Batchelor
John Marriott
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0152-x

Other articles of this Issue 6/2015

International Journal of Clinical Pharmacy 6/2015 Go to the issue